![Arun Swaminathan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Arun Swaminathan
Vorstandsvorsitzender bei
COYA THERAPEUTICS, INC.
Vermögen: 48 200 $ am 31.05.2026
Profil
Arun Swaminathan was the founder of Lynkogen, Inc., founded in 2016, where the title held was Chief Executive Officer from 2016 to 2020.
Dr. Swaminathan is currently Chief Executive Officer & Director at Coya Therapeutics, Inc. since 2024.
Former jobs include Director-Worldwide Brand at Bristol Myers Squibb Co., Head-Marketing at Labcorp Drug Development, Inc., Chief Business Officer at Actinium Pharmaceuticals, Inc. from 2022 to 2023, and Chief Business Officer & Senior Vice President at Alteogen, Inc. from 2018 to 2021.
Education includes a doctorate from the University of Pittsburgh and an undergraduate degree from the University of Madras.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.05.2026 | 10’000 ( 0.04% ) | 48 200 $ | 31.05.2026 |
Aktive Positionen von Arun Swaminathan
| Unternehmen | Position | Beginn |
|---|---|---|
| COYA THERAPEUTICS, INC. | Vorstandsvorsitzender | 01.11.2024 |
Ehemalige bekannte Positionen von Arun Swaminathan
| Unternehmen | Position | Ende |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.03.2023 |
| ALTEOGEN INC. | Corporate Officer/Principal | 01.09.2021 |
Lynkogen, Inc. | Vorstandsvorsitzender | 01.03.2020 |
| COVANCE INC. | Vertrieb & Marketing | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Ausbildung von Arun Swaminathan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
3
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Medical/Nursing ServicesHealth Services Provides medical laboratory testing and drug development services | Health Services |
University of Pittsburgh
 University of Pittsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Madras
 University of Madras Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actinium Pharmaceuticals, Inc.
 Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
Alteogen, Inc.
 Alteogen, Inc. BiotechnologyHealth Technology Engages in the research and development of biopharmaceuticals | Health Technology |
Coya Therapeutics, Inc.
 Coya Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on research and development of therapies to enhance the function of regulatory T cells | Health Technology |
Lynkogen, Inc. |
